Resources | NITAG RESOURCE CENTER

2024 ∙ Louise Henaff, Dace Zavadska, Mario Melgar, Johanna Fihman, Christoph Steffen, Joachim Hombach

The role of NITAGs in government decisions on vaccine use: insights from the Fifth Global NITAG Network meeting

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2023 ∙ JCVI

JCVI statement on a childhood varicella (chickenpox) vaccination programme

2023 ∙ JCVI

JCVI statement on the COVID-19 vaccination programme for autumn 2023 - updated on October 2023

2023 ∙ NIAC

NIAC RECOMMENDATIONS FOR PASSIVE IMMUNISATION AND VACCINATION AGAINST RESPIRATORY SYNCYTIAL VIRUS IN INFANTS, CHILDREN AND OLDER ADULTS

2023 ∙ ATAGI

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

2023 ∙ NACI

Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19

2023 ∙ STIKO

Recommendations by the Standing Committee on Vaccination (STIKO) at the Robert Koch Institute – 2023

2023 ∙ ACIP

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season

2023

Routine vaccination programme against COVID-19 in the Netherlands